Curasore

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Curasore
Generic name: PRAMOXINE HYDROCHLORIDE
Manufacturer: S.S.S. Company
Product type: HUMAN OTC DRUG
SPL set ID: 6891e5aa-e6f2-4355-8ee9-d23c9959787e
SPL ID: 47e0a9b6-4f7a-b034-e063-6394a90a64ba
Version: 7
Effective date: 2026-01-08
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:18:56

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Curasore	openfda.brand_name
generic name		PRAMOXINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		S.S.S. Company	openfda.manufacturer_name
ndc	package	12258-223-05	openfda.package_ndc
ndc	product	12258-223	openfda.product_ndc
ndc11	package	12258022305	derived:openfda.package_ndc
rxcui		1294034	openfda.rxcui
rxcui		2109512	openfda.rxcui
spl id		47e0a9b6-4f7a-b034-e063-6394a90a64ba	id
spl set id		6891e5aa-e6f2-4355-8ee9-d23c9959787e	set_id
unii		88AYB867L5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product Do not swallow Avoid contact with the eyes Avoid contact with the nose Stop use and consult a doctor If Redness Swelling Irritation or pain persists or increases, condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor. Keep out of the reach of children In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.